Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease (COPD)

Explore clinical trials studying Chronic Obstructive Pulmonary Disease (COPD). Study availability and eligibility vary by location and protocol.

428 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease (COPD) trial results

Completed

Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease

NCT01111487

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • HCPA - Hospital of Clinicas of Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
  • Federal University of Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil
  • University of Santa Cruz do Sul Santa Cruz do Sul, Rio Grande do Sul, Brazil
View Trial Details
Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

NCT00877383

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Anniston, Alabama, United States
  • Novartis Investigator Site Birmingham, Alabama, United States
  • Novartis Investigator Site Jasper, Alabama, United States
  • Novartis Investigator Site Mobile, Alabama, United States
View all 176 locations
View Trial Details
Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

NCT00846586

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Birmingham, Alabama, United States
  • Novartis Investigator Site Mobile, Alabama, United States
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 137 locations
View Trial Details
Completed

Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)

NCT00821093

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +10 more
Locations
  • Novartis Investigator Site Anniston, Alabama, United States
  • Novartis Investigator Site Fairhope, Alabama, United States
  • Novartis Investigator Site Jasper, Alabama, United States
  • Novartis Investigator Site Mobile, Alabama, United States
View all 144 locations
View Trial Details
Completed

Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)

NCT00792805

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Adelaide, Australia
  • Novartis Investigative Site Clayton, Australia
  • Novartis Investigative Site Daw Park, Australia
  • Novartis Investigative Site Beijing, China
View all 15 locations
View Trial Details
Completed

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00794157

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Hong Kong
  • Novartis Investigator Site New Territories, Hong Kong
  • Novartis Investigative Site Ahmedabad, India
  • Novartis Investigator Site Bangalore, India
View all 60 locations
View Trial Details
Completed

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00615030

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Beuvry, France
  • Novartis Investigative Site Nantes, France
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Hamburg, Germany
View Trial Details
Completed

A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

NCT00615459

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative site Camperdown, Australia
  • Novartis Investigator Site Gauting, Germany
  • Novartis Investigator Site Großhansdorf, Germany
  • Novartis Investigator Site Mainz, Germany
View all 20 locations
View Trial Details

Related conditions